» Articles » PMID: 24991269

Automated Solid-phase Peptide Synthesis to Obtain Therapeutic Peptides

Overview
Specialty Chemistry
Date 2014 Jul 4
PMID 24991269
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The great versatility and the inherent high affinities of peptides for their respective targets have led to tremendous progress for therapeutic applications in the last years. In order to increase the drugability of these frequently unstable and rapidly cleared molecules, chemical modifications are of great interest. Automated solid-phase peptide synthesis (SPPS) offers a suitable technology to produce chemically engineered peptides. This review concentrates on the application of SPPS by Fmoc/t-Bu protecting-group strategy, which is most commonly used. Critical issues and suggestions for the synthesis are covered. The development of automated methods from conventional to essentially improved microwave-assisted instruments is discussed. In order to improve pharmacokinetic properties of peptides, lipidation and PEGylation are described as covalent conjugation methods, which can be applied by a combination of automated and manual synthesis approaches. The synthesis and application of SPPS is described for neuropeptide Y receptor analogs as an example for bioactive hormones. The applied strategies represent innovative and potent methods for the development of novel peptide drug candidates that can be manufactured with optimized automated synthesis technologies.

Citing Articles

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.


Bioactive Peptides from Milk Proteins with Antioxidant, Anti-Inflammatory, and Antihypertensive Activities.

Borges T, Coelho P, Prudencio C, Gomes A, Gomes P, Ferraz R Foods. 2025; 14(3).

PMID: 39942128 PMC: 11816975. DOI: 10.3390/foods14030535.


Peptide Design for Enhanced Anti-Melanogenesis: Optimizing Molecular Weight, Polarity, and Cyclization.

Putri S, Maharani R, Maksum I, Siahaan T Drug Des Devel Ther. 2025; 19:645-670.

PMID: 39896936 PMC: 11784279. DOI: 10.2147/DDDT.S500004.


Current research trends and hotspots of boron neutron capture therapy: a bibliometric and visualization analysis.

Cong Y, Abulimiti M, Matsumoto Y, Jin J Front Oncol. 2024; 14:1507157.

PMID: 39726703 PMC: 11669655. DOI: 10.3389/fonc.2024.1507157.


Highly reliable and efficient encoding systems for hexadecimal polypeptide-based data storage.

Ren Y, Zhang Y, Liu Y, Wu Q, Hu H, Li J Fundam Res. 2024; 3(2):298-304.

PMID: 38932929 PMC: 11197718. DOI: 10.1016/j.fmre.2021.11.030.


References
1.
Hofmann S, Frank R, Hey-Hawkins E, Beck-Sickinger A, Schmidt P . Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes. Neuropeptides. 2013; 47(2):59-66. DOI: 10.1016/j.npep.2012.12.001. View

2.
Veronese F, Pasut G . PEGylation, successful approach to drug delivery. Drug Discov Today. 2005; 10(21):1451-8. DOI: 10.1016/S1359-6446(05)03575-0. View

3.
Geysen H, Meloen R, Barteling S . Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A. 1984; 81(13):3998-4002. PMC: 345355. DOI: 10.1073/pnas.81.13.3998. View

4.
Barany G, MERRIFIELD R . A new amino protecting group removable by reduction. Chemistry of the dithiasuccinoyl (Dts) function. J Am Chem Soc. 1977; 99(22):7363-5. DOI: 10.1021/ja00464a050. View

5.
Garcia-Martin F, Quintanar-Audelo M, Garcia-Ramos Y, Cruz L, Gravel C, Furic R . ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides. J Comb Chem. 2006; 8(2):213-20. DOI: 10.1021/cc0600019. View